3,4-甲基二氧化甲胺 (MDMA;狂喜) 作为心理治疗中的治疗辅助剂及其安全性问题
1Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, Sydney, NSW, 2065, Australia. babaldo@iinet.net.au.
Archives of toxicology
|May 14, 2024
概括
3,4-甲基二氧化甲胺 (MDMA) 显示为治疗创伤后应激障碍和其他疾病的治疗方法. 最近的临床试验和监管转变表明,在MDMA辅助心理治疗方面可能会取得突破.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 临床心理学 临床心理学
背景情况:
- 3,4-甲基二氧化甲胺 (MDMA) 是一种触媒原体,由于其被归类为毒品,因此面临研究限制.
- 麻醉药对神经递质运输体 (多巴胺,北上腺素,血清素) 产生影响,并对各种受体,特别是5-HT2A,充当激动剂.
研究的目的:
- 审查与MDMA相关的药理效应,治疗潜力和不良事件.
- 检查不断变化的监管环境和正在进行的MDMA辅助疗法的临床试验.
主要方法:
- 对MDMA的神经化学和受体相互作用的文献综述.
- 分析临床试验数据和有关MDMA的监管决策,用于各种疾病.
- 副作用和安全考虑的总结.
主要成果:
- MDMA的情绪改变,止痛和抗焦虑作用与5-HT2A受体激动有关.
- 用MDMA辅助治疗显示出治疗创伤后应激障碍 (PTSD) 的潜力,最近FDA批准了第三阶段试验.
- 像TGA这样的监管机构正在允许对PTSD的MDMA处方,试验正在探索其在精神分裂症,酒精使用障碍和社会焦虑症中的使用.
结论:
- MDMA显示出显著的治疗潜力,特别是在PTSD的心理治疗中.
- 目前正在进行的研究和监管转变表明,对各种精神疾病的MDMA辅助治疗有更广泛的接受.
- 虽然存在不良影响,但它们往往是短暂的,当单独使用MDMA时,死亡很少发生.
相关概念视频
CNS Stimulants: Psychedelic Agents
147
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
147
Electroconvulsive Therapy
36
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
36
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Hallucinogens and Psychedelics
164
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
164
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
Modeling in Therapy
71
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
71


